CD8A and neoplasm: Compared to other groups, the percentages of CD4+ T cells (24.2% in distant tumors and 18.4% in the spleen) and CD8+ T cells (9.65% in distant tumors and 51.7% in the spleen) were significantly higher, indicating that P1e/2b under US exposure exhibits strong tumor eradication capability by activating immune responses.